We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
President Trump announced Wednesday that he is invoking the Defense Production Act in response to the growing coronavirus pandemic, enabling the federal government to order private industry to manufacture emergency medical supplies. Read More
The EMA’s Pharmacovigilance Risk Assessment Committee (PRAC) found that certain cancer medicines that contain ifosfamide, an injectable chemotherapy drug, pose higher risks of brain damage in solution form than in powder form. Read More
An Indian drug manufacturer’s facility in Salcete, Goa drew a warning letter from the FDA for serious violations, including inadequate cleaning that left drug product residues inside manufacturing equipment. Read More
Drug industry trade groups PhRMA and BIO expressed a strong distaste for the Trump administration’s strategy for tackling high drug prices by importing Canadian medicines, arguing that the plan would fail to lower costs and could put patients at risk. Read More
Regeneron has identified hundreds of coronavirus antibodies for developing treatments for COVID-19 and hopes to start clinical trials by early summer. Read More
The first U.S. clinical trial for a coronavirus vaccine got under way yesterday — a phase 1 trial of Moderna’s mRNA-1273 in collaboration with the National Institutes of Health. Read More